Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
5
×
boston blog main
inclisiran
5
×
life sciences
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
boston top stories
national top stories
alirocumab
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
evolocumab
indiana blog main
indiana top stories
medicines co.
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
cholesterol
evercore isi
fda
glaxosmithkline
What
cholesterol
drug
new
lowering
medco
medicines
roundup
wave
abbvie’s
according
acquire
agreed
akcea
alnylam
barbecuing
based
billion
bio
biotech
brings
camping
cardiologist
cases
cash
center
centers
check
cigarettes
company
compound
conference
control
data
day
deal
deaths
disease
drugs
electronic
evidence
Language
unset
Current search:
inclisiran
×
biotech
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms